ICP Parking Lot/Vaccines: Difference between revisions
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
=[[Vaccines/Bibliography|Bibliography]]= | =[[Vaccines/Bibliography|Bibliography]]= | ||
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf | * 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf | ||
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf | * Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf | ||
* Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/. | * Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/. | ||
* LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf | * LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf | ||
* Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med. | |||
* University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med. | |||
* The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med. | |||
* New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med. | |||
* Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med. | |||
* Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med. | |||
* Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med. | |||
* Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med. | |||
* Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med. | |||
* Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott | |||
=Navigation= | =Navigation= | ||
Back to [[Main Page]] | Back to [[Main Page]] | ||
Back to [[Biotechnology_-_Genomic_and_Proteomics]] | Back to [[Biotechnology_-_Genomic_and_Proteomics]] | ||
Revision as of 20:58, 5 May 2010
Bibliography
- 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
- Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
- Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
- LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
- Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
- University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
- The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
- New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
- Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
- Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
- Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
- Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
- Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
- Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott
Back to Main Page Back to Biotechnology_-_Genomic_and_Proteomics